Teva announces yet another management shuffle: http://www.sec.gov/Archives/edgar/data/818686/000130901414000380/exhibit1.htm Sigurdur Olafsson has been hired from ACT to head Teva’s new Global Generic Drugs segment. I think this is Teva's third organizational restructuring in the past few years, but I’ve lost count. Comments?